Circio Holding ASA (OSL:CRNA) 3-Year EBITDA Growth Rate : 26.40% (As of Dec. 2023)

View and export this data going back to 2016. Start your Free Trial

What is Circio Holding ASA 3-Year EBITDA Growth Rate?

Circio Holding ASA's EBITDA per Share for the three months ended in Dec. 2023 was kr0.00.

During the past 3 years, the average EBITDA Per Share Growth Rate was 26.40% per year. During the past 5 years, the average EBITDA Per Share Growth Rate was 46.10% per year. During the past 10 years, the average EBITDA Per Share Growth Rate was 15.60% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average EBITDA per share growth rate.

During the past 12 years, the highest 3-Year average EBITDA Per Share Growth Rate of Circio Holding ASA was 79.20% per year. The lowest was -131.50% per year. And the median was 12.00% per year.

Competitive Comparison of Circio Holding ASA's 3-Year EBITDA Growth Rate

For the Biotechnology subindustry, Circio Holding ASA's 3-Year EBITDA Growth Rate, along with its competitors' market caps and 3-Year EBITDA Growth Rate data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Circio Holding ASA's 3-Year EBITDA Growth Rate Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Circio Holding ASA's 3-Year EBITDA Growth Rate distribution charts can be found below:

* The bar in red indicates where Circio Holding ASA's 3-Year EBITDA Growth Rate falls into.

Circio Holding ASA 3-Year EBITDA Growth Rate Calculation

This is the 3-year average growth rate of EBITDA per Share. The growth rate is calculated using exponential compounding based on the latest four year annual data.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average EBITDA per share growth rate.

Circio Holding ASA (OSL:CRNA) 3-Year EBITDA Growth Rate Explanation

EBITDA per Share is the amount of Earnings Before Interest, Taxes, Depreciation, and Amortization (EBITDA) per outstanding share of the company's stock.

Earnings Before Interest, Taxes, Depreciation, and Amortization (EBITDA) is what the company earns before it expenses interest, taxes, depreciation and amortization.

Circio Holding ASA 3-Year EBITDA Growth Rate Related Terms

Thank you for viewing the detailed overview of Circio Holding ASA's 3-Year EBITDA Growth Rate provided by GuruFocus.com. Please click on the following links to see related term pages.

Circio Holding ASA (OSL:CRNA) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Circio Holding ASA (OSL:CRNA) » Definitions » 3-Year EBITDA Growth Rate

Comparable Companies

Traded in Other Exchanges

TA50:Germany

Address

Vollsveien 19, Lysaker, Oslo, NOR, 1366

Website

https://www.circio.com

Circio Holding ASA is a clinical-stage company. It is focused on developing and commercializing immuno-oncology therapies to target treatment-resistant solid tumors. Its product candidate, ONCOS-102, is a genetically modified oncolytic adenovirus, which has been engineered to infect cancer cells and activate the immune system to fight cancer. It includes the development and implementation with the purpose of developing targeted immunotherapy treatments for cancer patients.

Circio Holding ASA (OSL:CRNA) Headlines

No Headlines